January 28, 2014

Roxane Labs announced the launch of telmisartan tablets USP, an authorized generic version of Boehringer Ingelheim's Micardis tablets.

January 10, 2014

The Food and Drug Administration has approved a generic drug for high blood pressure made by Actavis, the company said Friday.

October 15, 2012

Watson Pharmaceuticals announced that its subsidiary, Watson Laboratories, has received Food and Drug Administration approval on its abbreviated new drug application for irbesartan tablets — the generic equivalent to Sanofi's Avapro — in the 75-mg, 150-mg and 300-mg strengths.

September 28, 2012

Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday.

April 2, 2012

Teva Pharmaceutical Industries has launched generic versions of two blood pressure drugs made by Sanofi, Teva said Monday.

December 21, 2011

The Food and Drug Administration has approved a new drug for high blood pressure made by Takeda, the drug maker said.

June 13, 2011

The Food and Drug Administration has approved changes to the labels of several drugs made by Merck, the agency said Friday.

May 24, 2011

A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.

February 22, 2011

In line with American Heart Month, Boehringer Ingelheim's Micardis has introduced a cardiovascular risk-reduction calculator, designed to assess patients' cardiovascular risk.

October 14, 2010

The Food and Drug Administration has approved two generic drugs by Mylan for treating hypertension,...

October 11, 2010

Actavis has received regulatory approval from the Food and Drug Administration for its high blood...

September 27, 2010

The market for hypertension drugs will drop by $3 billion by the end of the...

June 10, 2010

The Food and Drug Administration said Friday it was evaluating data from two clinical trials...